Latest Conference Articles

ICYMI: Denise Visco, MD, shares the take-home message from her 2019 ASCRS presentation.

ICYMI: Dr. Clark breaks down the results of the PANORAMA Study

ICYMI: Dr. Singh shares the take-home message from his 2019 presentation

ICMYI: Dr. Wykoff discusses results from his ASRS presentation

Dr. Kaiser discusses how risuteganib fared in a phase II trial in patients with intermediate nonexudative AMD. 

ICYMI: Dr. Blinder compares the efficiencies between two surgical cutters

Eyes with persistent subretinal fluid fared better with visual acuity than eyes that were dry, according to the HARBOR Trial

ICYMI: Abicipar Phase II MAPLE Trial supports improved safety for patients with nAMD following a Modified Manufacturing Process

Glaucoma genetics research can define the molecular basis of glaucoma and targets for developing curative or even preventive therapies, and it also pro-vides a basis for diagnostic and screening tests.

While MIGS has forever changed the surgical management of glaucoma, the space continues to evolve.

ICYMI: Here's what's in the 2019 pipeline

This year’s ASRS PAT survey show subtle regional differences

 The ASRS Global Trends Survey finds differences in some treatment preferences

ICYMI: Dr. Packer shares the pearls from his 2019 ASCRS presentation 

ICYMI: ASRS-developed program aims to support physicians with confidential comparisons

Ever wondered what it's like to compete in a Shark Tank-like competition? Find out!

Optical coherence tomography angiography can detect microcirculatory disturbances during acute attacks.